Category

Stocks to Watch

Stocks

Should I Buy Valeant Stock After Q4 2015 Earnings?

Valeant not only missed expectations in its Q4 2015 earnings report, but also provided a bleak outlook for 2016.

The drug maker has dealt with countless scandals over the past six months, which has made the Valeant stock price plunge over 78% from its 52-week high of $263.81.

Now, some on Wall Street are saying that this is a great time to buy VRX at a discount. But here's what you really need to know...

Gold

The "BANG Stocks" Are the Next Group of Profit-Doublers

The market-leading FANG stocks – Facebook, Amazon.com, Netflix, and the former Google, now Alphabet – haven't had a great 2016, with returns in the neighborhood of -15% to just under 5% for the year.

Don't get me wrong – they're still good "holds" for investors wise enough to take the long view and accumulate big, steady gains over a period of years.

Those anemic gains aren't surprising, given that we're all but "officially" in the depths of a bear market.

But… like the old adage goes, "there's always a bull market somewhere," and I believe that's especially true of the basket of stocks I'm about to show you. As uncertainty and volatility rule the markets, these shares have already delivered bona fide breakout gains that most investors would kill for right now.

But you haven't missed out; there's a new technology just hitting its stride right now that could multiply these players' profits exponentially.

And the best part is they're all still available at real bargain prices.

They won't stay that way, though...

Biotechnology

Why the GWPH Stock Price Soared 130% Today and What's Next

The GWPH stock price soared more than 130% to $88.22 a share this morning (Monday) morning after GW Pharmaceuticals Plc. (Nasdaq ADR: GWPH) announced positive phase 3 study results for its investigational cannabidiol drug, Epidiolex.

Epidiolex is designed to treat Dravet syndrome. Also known as severe myoclonic epilepsy of infancy (SMEI), Dravet syndrome is a type of epilepsy with often fatal seizures.

Here's what else investors need to know...

Technology

Tesla Stock Price's 40% Gain This Month Is Just the Start

The Tesla stock price has surged more than 40% in the last month alone, making it one of the hottest stocks on the market. During the same time, the Dow Jones Industrial Average, S&P 500, and Nasdaq have posted gains of just 7%, 8%, and 10%, respectively.

And we see those types of market-beating gains from the Tesla Motors Inc. (Nasdaq: TSLA) stock price continuing from here.

But before we get to the long-term outlook for Tesla stock, here's why it has soared this month...